We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
What's in the Cards for CME Group This Earnings Season?
Read MoreHide Full Article
Key Takeaways
CME Group is expected to benefit from market data growth and higher clearing and transaction fee income.
CME's equity index and agricultural volumes rose, while interest rate, energy and FX trading declined.
Higher employee compensation and technology investments are expected to increase quarterly expenses.
CME Group Inc. (CME - Free Report) is expected to register a decline in both top and bottom lines when it reports second-quarter 2026 results on July 22, before the opening bell.
The Zacks Consensus Estimate for CME’s second-quarter revenues is pegged at $1.69 billion, indicating a 0.1% decrease from the year-ago reported figure.
The consensus estimate for earnings is pegged at $2.93 per share. The Zacks Consensus Estimate for CME’s second-quarter earnings has moved 2.3% south in the past 30 days. The estimate suggests a year-over-year decrease of 1%.
What the Zacks Model Says
Our proven model does not conclusively predict an earnings beat for CME Group this time around. This is because the stock has the right combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold), which increases the chances of an earnings beat. This is not the case, as you can see below.
Earnings ESP: CME Group has an Earnings ESP of -1.04%. This is because the Most Accurate Estimate of $2.90 is pegged lower than the Zacks Consensus Estimate of $2.93. You can uncover the best stocks to buy or sell before they are reported with our Earnings ESP Filter.
Zacks Rank: CME Group currently carries a Zacks Rank of 4 (Sell).
Factors Likely to Shape Q2 Results
CME Group’s second-quarter results are likely to benefit from its diversified product portfolio, heightened market volatility and strong competitive position.
Revenue growth is likely to have been aided by gains in market data and information services, as well as higher clearing, transaction and other fee-based income.
Increased volatility across asset classes appears to have boosted trading volumes, which, in turn, supported clearing and transaction fees. The Zacks Consensus Estimate for clearing and transaction fees stands at $1.4 billion, indicating a 1.7% decrease compared with the same period last year.
CME Group reported a quarterly average daily volume (ADV) of 29.8 million contracts in the second quarter, which declined 1% year over year. Trading activity decreases across multiple segments, including interest rates, energy and foreign exchange. Agricultural ADV of 2.1 million contracts in the second quarter of 2026 increased 6% from the prior-year period. Equity Index ADV of 8.6 million contracts increased 13% year over year.
Market data and information services revenues are likely to have benefited from pricing adjustments on certain products as well as increased demand and usage. The Zacks Consensus Estimate for this segment is pegged at $227 million, suggesting a 14.6% year-over-year increase.
On the cost side, expenses are expected to have risen during the quarter, primarily due to higher spending on employee compensation and benefits, along with increased investment in technology.
Stocks to Consider
Here are three finance stocks you may want to consider, as our model shows that these also have the right combination of elements to post an earnings beat.
Cboe Global Markets, Inc. (CBOE - Free Report) has an Earnings ESP of +1.82% and carries a Zacks Rank #2 at present. The Zacks Consensus Estimate for second-quarter 2026 earnings is pegged at $3.41, indicating a year-over-year increase of 38.6%. You can see the complete list of today’s Zacks #1 Rank stocks here.
CBOE’s earnings beat estimates in each of the last four reported quarters.
Cincinnati Financial Corporation (CINF - Free Report) has an Earnings ESP of +8.84% and a Zacks Rank #2 at present. The Zacks Consensus Estimate for second-quarter 2026 earnings is pegged at $1.77, indicating a year-over-year decrease of 10.1%.
CINF’s earnings beat estimates in each of the last four reported quarters.
The Allstate Corporation (ALL - Free Report) has an Earnings ESP of +23.32% and a Zacks Rank #3 at present. The Zacks Consensus Estimate for second-quarter 2026 earnings is pegged at $4.92, indicating a year-over-year decrease of 17.1%.
ALL’s earnings beat estimates in each of the last four reported quarters.
View the Zacks #1 Rank List
Image: Bigstock
What's in the Cards for CME Group This Earnings Season?
Key Takeaways
CME Group Inc. (CME - Free Report) is expected to register a decline in both top and bottom lines when it reports second-quarter 2026 results on July 22, before the opening bell.
The Zacks Consensus Estimate for CME’s second-quarter revenues is pegged at $1.69 billion, indicating a 0.1% decrease from the year-ago reported figure.
The consensus estimate for earnings is pegged at $2.93 per share. The Zacks Consensus Estimate for CME’s second-quarter earnings has moved 2.3% south in the past 30 days. The estimate suggests a year-over-year decrease of 1%.
What the Zacks Model Says
Our proven model does not conclusively predict an earnings beat for CME Group this time around. This is because the stock has the right combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold), which increases the chances of an earnings beat. This is not the case, as you can see below.
Earnings ESP: CME Group has an Earnings ESP of -1.04%. This is because the Most Accurate Estimate of $2.90 is pegged lower than the Zacks Consensus Estimate of $2.93. You can uncover the best stocks to buy or sell before they are reported with our Earnings ESP Filter.
CME Group Inc. Price and EPS Surprise
CME Group Inc. price-eps-surprise | CME Group Inc. Quote
Zacks Rank: CME Group currently carries a Zacks Rank of 4 (Sell).
Factors Likely to Shape Q2 Results
CME Group’s second-quarter results are likely to benefit from its diversified product portfolio, heightened market volatility and strong competitive position.
Revenue growth is likely to have been aided by gains in market data and information services, as well as higher clearing, transaction and other fee-based income.
Increased volatility across asset classes appears to have boosted trading volumes, which, in turn, supported clearing and transaction fees. The Zacks Consensus Estimate for clearing and transaction fees stands at $1.4 billion, indicating a 1.7% decrease compared with the same period last year.
CME Group reported a quarterly average daily volume (ADV) of 29.8 million contracts in the second quarter, which declined 1% year over year. Trading activity decreases across multiple segments, including interest rates, energy and foreign exchange. Agricultural ADV of 2.1 million contracts in the second quarter of 2026 increased 6% from the prior-year period. Equity Index ADV of 8.6 million contracts increased 13% year over year.
Market data and information services revenues are likely to have benefited from pricing adjustments on certain products as well as increased demand and usage. The Zacks Consensus Estimate for this segment is pegged at $227 million, suggesting a 14.6% year-over-year increase.
On the cost side, expenses are expected to have risen during the quarter, primarily due to higher spending on employee compensation and benefits, along with increased investment in technology.
Stocks to Consider
Here are three finance stocks you may want to consider, as our model shows that these also have the right combination of elements to post an earnings beat.
Cboe Global Markets, Inc. (CBOE - Free Report) has an Earnings ESP of +1.82% and carries a Zacks Rank #2 at present. The Zacks Consensus Estimate for second-quarter 2026 earnings is pegged at $3.41, indicating a year-over-year increase of 38.6%. You can see the complete list of today’s Zacks #1 Rank stocks here.
CBOE’s earnings beat estimates in each of the last four reported quarters.
Cincinnati Financial Corporation (CINF - Free Report) has an Earnings ESP of +8.84% and a Zacks Rank #2 at present. The Zacks Consensus Estimate for second-quarter 2026 earnings is pegged at $1.77, indicating a year-over-year decrease of 10.1%.
CINF’s earnings beat estimates in each of the last four reported quarters.
The Allstate Corporation (ALL - Free Report) has an Earnings ESP of +23.32% and a Zacks Rank #3 at present. The Zacks Consensus Estimate for second-quarter 2026 earnings is pegged at $4.92, indicating a year-over-year decrease of 17.1%.
ALL’s earnings beat estimates in each of the last four reported quarters.